Companies: 10,795·Total market cap: $144.5T
Cutera, Inc.

Cutera, Inc.

CUTRNASDAQHealthcare
$0.10
+$0.00(+0.00%)
Market Cap$1956014
P/E Ratio
52W High$3
52W Low$0.0133
Overview

Cutera, Inc. (CUTR) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

cutr · pe ratio · data through Dec 31, 2023

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Cutera, Inc. (CUTR) measures how much investors pay for each dollar of the company's trailing earnings. CUTR's current PE ratio of N/A is calculated by dividing its stock price of $0.10 by its TTM earnings per share of -$8.19.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31

Forward P/E
N/A
FY2026 est. EPS $-1.94
Based on 1 analyst
EPS (TTM)
-$8.19
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cutera, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2004 – 2023 · Annual
PE Ratio (TTM)
5Y Avg 129.6x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 7 fiscal years · Front-end computed
Average
99.8x
7-yr mean
Median
28.5x
7-yr midpoint
Minimum
19.7x
Lowest year
Maximum
358.5x
Highest year
19.7x
Min
Q1 · 25%28.5x
Median
Q3 · 75%358.5x
Max
Historically Low

At N/A, CUTR's current P/E is lower than in 0% of its annual fiscal year readings over the past 7 years — historically low.

0th percentileHigher than 0 of 7 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Cutera, Inc.
Cutera, Inc.You
CUTR
$2MN/A-$8.19
CareMax, Inc.
CareMax, Inc.
CMAX
$2MN/A-$183.30
Fresh2 Group Limited
Fresh2 Group Limited
FRES
$2MN/A-$106577.06
G Medical Innovations Holdings Ltd
G Medical Innovations Holdings Ltd
GMVD
$2MN/A$0.00
Vyome Holdings, Inc.
Vyome Holdings, Inc.
HIND
$13MN/A-$4.75
Midatech Pharma plc
Midatech Pharma plc
MTP
$2MN/A-$0.00
NAYA Biosciences, Inc.
NAYA Biosciences, Inc.
NAYA
$1MN/A-$29.39

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2023-12-31Latest
FY2023
$-8.19
2022-12-31
FY2022
$-4.39
2021-12-31
FY2021
358.51x$0.12
2020-12-31
FY2020
$-1.43
2019-12-31
FY2019
$-0.88
2018-12-31
FY2018
$-2.23
2017-12-31
FY2017
20.98x$2.16-76.4%
2016-12-31
FY2016
89.04x$0.19
2015-12-31
FY2015
$-0.32
2014-12-31
FY2014
$-0.74

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Cutera, Inc. (CUTR) measures how much investors pay for each dollar of the company's trailing earnings. CUTR's current PE ratio of N/A is calculated by dividing its stock price of $0.10 by its TTM earnings per share of -$8.19.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.10 ÷ -$8.19 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

CUTR pe ratio · 6 questions

CUTR's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.10 and TTM EPS of -$8.19. Data sourced from Financial Modeling Prep via CUTR's SEC 10-K and 10-Q filings.

CUTR PE ratioWhat is CUTR PE ratioCurrent PE ratio of CUTRCUTR PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cutera, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09